Cargando…

Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens

BACKGROUND: High-risk human papillomavirus (HR HPV) testing is already part of cervical cancer screening programs in a number of countries. New tests need to be validated not only in clinical studies but also in routine screening settings with regard to their clinical performance. METHODS: The Abbot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iftner, Thomas, Wang, Lisa, Iftner, Angelika, Holz, Barbara, Haedicke-Jarboui, Juliane, Iftner, Nathalie, von Wasielewski, Reinhard, Martus, Peter, Boehmer, Gerd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106810/ https://www.ncbi.nlm.nih.gov/pubmed/27835974 http://dx.doi.org/10.1186/s12879-016-1994-0

Ejemplares similares

A population-based observational study comparing Cervista and Hybrid Capture 2 methods: improved relative specificity of the Cervista assay by increasing its cut-off
por: Boehmer, Gerd, et al.
Publicado: (2014)

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
por: Iftner, Thomas, et al.
Publicado: (2019)

Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based economic evaluation
por: Weston, Georgie, et al.
Publicado: (2020)

Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis
por: Denecke, Agnieszka, et al.
Publicado: (2021)

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients
por: Petry, K-U, et al.
Publicado: (2003)

ThinPrep cytology combined with HPV detection in the diagnosis of cervical lesions in 1622 patients
por: Husaiyin, Sulaiya, et al.
Publicado: (2021)

Prevalence of low-risk HPV types and genital warts in women born 1988/89 or 1983/84 -results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany
por: Petry, Karl Ulrich, et al.
Publicado: (2012)

HPV vaccination as preventive approach for recurrent respiratory papillomatosis - a 22-year retrospective clinical analysis
por: Mauz, Paul Stefan, et al.
Publicado: (2018)

Analytic performance of PANArray HPV and HPV 9G DNA chip tests for genotyping of high-risk human papillomavirus in cervical ThinPrep PreservCyt samples
por: Kim, Jiyoung, et al.
Publicado: (2019)

A case of recurrent respiratory papillomatosis with malignant transformation, HPV11 DNAemia, high L1 antibody titre and a fatal papillary endocardial lesion
por: Mauz, Paul-Stefan, et al.
Publicado: (2014)

Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers
por: Petry, Karl Ulrich, et al.
Publicado: (2017)

Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84 – results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany
por: Petry, Karl Ulrich, et al.
Publicado: (2013)

ThinPrep cytologic test combined with HPV typing to evaluate the degree of cervical diseases and the relationship between HPV typing and the pathological results of patients with atypical squamous cells of undetermined significance: a diagnostic test
por: Wang, Ling, et al.
Publicado: (2022)

Methylation of CpG 5962 in L1 of the human papillomavirus 16 genome as a potential predictive marker for viral persistence: A prospective large cohort study using cervical swab samples
por: Fertey, Jasmin, et al.
Publicado: (2019)

Cytomorphology of cervicovaginal melanoma: ThinPrep versus conventional Papanicolaou tests
por: Setia, Namrata, et al.
Publicado: (2010)

Comparison between the Roche Cobas 4800 Human Papillomavirus (HPV), Abbott RealTime High-Risk HPV, Seegene Anyplex II HPV28, and Novel Seegene Allplex HPV28 Assays for High-Risk HPV Detection and Genotyping in Mocked Self-Samples
por: Bell, Margo, et al.
Publicado: (2023)

Follow-up study on ThinPrep cytology test-positive patients in tropical regions
por: Chen, Yun-Chun, et al.
Publicado: (2022)

Prevalence of high-risk human papilloma virus in women with high-grade squamous cell intraepithelial lesions in Botswana using Abbott RealTime HPV assay
por: Rantshabeng, Patricia, et al.
Publicado: (2019)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Human papillomavirus (HPV) detection in vaginal self-samples: evaluation of eNat® as an alternative suspension medium to ThinPrep®PreservCyt® for vaginal swabs
por: Giubbi, Chiara, et al.
Publicado: (2022)

Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off
por: Boers, Aniek, et al.
Publicado: (2014)

Absence of Severe Acute Respiratory Syndrome-Coronavirus-2 RNA in ocular tissues
por: Bayyoud, Tarek, et al.
Publicado: (2020)

Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid
por: Rabaan, Ali A., et al.
Publicado: (2018)

Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse
por: Mittelstadt, Suzana, et al.
Publicado: (2023)

Comparison of Roche TaqMan v.2.0, Abbott RealTime and Modified Abbott Residual Viremia Assays in Testing of Routine Samples for Viremia Monitoring in HIV Care
por: Mckinnon, John, et al.
Publicado: (2017)

Performance of careHPV, hybrid capture 2 and visual inspection with acetic acid for detection of high-grade cervical lesion in Tanzania: A cross-sectional study
por: Katanga, Johnson, et al.
Publicado: (2019)

Evaluation of the analytical performance and specificity of a SARS-CoV-2 transcription-mediated amplification assay
por: Schneider, Markus, et al.
Publicado: (2021)

Detection of in situ and invasive endocervical adenocarcinoma on ThinPrep Pap Test: Morphologic analysis of false negative cases
por: Chaump, Michael, et al.
Publicado: (2016)

Development of Whole Slide Imaging on Smartphones and Evaluation With ThinPrep Cytology Test Samples: Follow-Up Study
por: Huang, Yu-Ning, et al.
Publicado: (2018)

hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
por: Carozzi, F, et al.
Publicado: (2013)

An efficient method that combines the ThinPrep cytologic test with E6/E7 mRNA testing for cervical cancer screening
por: Pan, Dan, et al.
Publicado: (2019)

Human papillomavirus detection using the Abbott RealTime high-risk HPV tests compared with conventional nested PCR coupled to high-throughput sequencing of amplification products in cervical smear specimens from a Gabonese female population
por: Moussavou-Boundzanga, Pamela, et al.
Publicado: (2017)

Performance of the Abbott RealTime MTB RIF/INH resistance assay when used to test Mycobacterium tuberculosis specimens from Bangladesh
por: Kostera, Joshua, et al.
Publicado: (2018)

Comparison of the detection rate of cervical lesion with TruScreen, LBC test and HPV test: A Real-world study based on population screening of cervical cancer in rural areas of China
por: Ma, Yu, et al.
Publicado: (2020)

HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows
por: Huijsmans, Cornelis Johannes Jacobus, et al.
Publicado: (2016)

Artificial classification of cervical squamous lesions in ThinPrep cytologic tests using a deep convolutional neural network
por: Liu, Li, et al.
Publicado: (2020)

Type distribution of human papillomaviruses in ThinPrep cytology samples and HPV16/18 E6 gene variations in FFPE cervical cancer specimens in Fars province, Iran
por: Farhadi, Ali, et al.
Publicado: (2023)

Diagnostic performance of the Abbott RealTime MTB assay for tuberculosis diagnosis in people living with HIV
por: Saavedra, Belén, et al.
Publicado: (2021)

Evidence for direct interaction between the oncogenic proteins E6 and E7 of high-risk human papillomavirus (HPV)
por: Lim, JiaWen, et al.
Publicado: (2023)

Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test
por: Mokhtari, Camelia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_10g6sediv9e4bkjpjmm3c68hpn